Status:
UNKNOWN
A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment
Lead Sponsor:
Kinhely Bio-tech Co., Ltd.
Collaborating Sponsors:
RenJi Hospital
Peking University
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
research topic:helios After registration of clinical research bidders:kinhely bio-tech Co.Ltd study design:A prospective single treatment group multicenter clinical study Number of patients:Included i...
Detailed Description
no desired
Eligibility Criteria
Inclusion
- Any age 18 to 80 sex Myocardial ischemia or angina pectoris of coronary artery disease An application stents diameter stenosis greater than 50% Comply with the instructions Voluntarily signed the informed consent form
Exclusion
- Pregnant women cardiac shock Intolerance to antithrombotic therapy or allergies 6 months prior to the start of the study involved in other studies Within 6 months after PCI plans to accept non cardiac surgery Non-compliant patient
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2015
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT01880879
Start Date
January 1 2013
End Date
January 1 2015
Last Update
June 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yan chai hospital affiliated to Shanghai jiaotong university school of medicine
Shanghai, Shanghai Municipality, China, 200127